Walleye Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Buy
29,300
+11,700
+66% +$4.01M 0.04% 451
2026
Q1
$6.19M Sell
17,600
-31,800
-64% -$11.3M 0.03% 666
2025
Q4
$16.2M Buy
49,400
+14,600
+42% +$4.63M 0.05% 389
2025
Q3
$9.82M Sell
34,800
-33,500
-49% -$9.72M 0.04% 557
2025
Q2
$19.1M Buy
68,300
+34,300
+101% +$9.72M 0.07% 250
2025
Q1
$10.6M Sell
34,000
-31,900
-48% -$9.42M 0.05% 423
2024
Q4
$17.2M Buy
65,900
+50,300
+322% +$14.9M 0.04% 380
2024
Q3
$5.03M Sell
15,600
-61,300
-80% -$20.1M 0.01% 1161
2024
Q2
$24M Buy
76,900
+600
+0.8% +$176K 0.04% 293
2024
Q1
$21.7M Sell
76,300
-12,000
-14% -$3.51M 0.04% 383
2023
Q4
$25.4M Buy
88,300
+38,100
+76% +$10.4M 0.05% 252
2023
Q3
$13.5M Buy
50,200
+29,300
+140% +$7.31M 0.03% 420
2023
Q2
$4.64M Buy
20,900
+15,800
+310% +$3.67M 0.02% 775
2023
Q1
$1.23M Sell
5,100
-5,900
-54% -$1.45M 0.02% 1014
2022
Q4
$2.89M Sell
11,000
-3,100
-22% -$831K 0.05% 429
2022
Q3
$3.18M Buy
+14,100
New +$3.42M 0.06% 346
2020
Q1
Sell
-7,500
Closed -$1.81M 884
2019
Q4
$1.81M Sell
7,500
-7,700
-51% -$1.7M 0.12% 229
2019
Q3
$2.94M Buy
15,200
+14,300
+1,589% +$2.74M 0.18% 133
2019
Q2
$166K Sell
900
-500
-36% -$89.5K 0.02% 1042
2019
Q1
$266K Buy
+1,400
New +$267K 0.04% 645
2018
Q3
$2.92M Buy
+14,100
New +$2.78M 1.36% 7

Other funds holding AMGN

Walleye Capital's AMGN Position: Q2 2026 in Review

Walleye Capital increased its Amgen (AMGN) stake by 961,172% in Q2 2026, buying an estimated $82.3M and bringing the position to 240,318 shares worth $87M. The position accounts for 0.31% of the portfolio, ranked #30.

Walleye Capital first reported a position in AMGN in Q2 2019 and has held it in 15 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Walleye Capital held 240,318 shares of Amgen worth $87M as of Q2 2026.
  • Walleye Capital bought 240,293 Amgen shares in Q2 2026, an estimated $82.3M.
  • Amgen made up 0.31% of Walleye Capital's portfolio in Q2 2026, its #30 holding.
  • Walleye Capital first reported a position in Amgen in Q2 2019 and has held it in 15 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.